Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Operating Margin Growth (3y) (2025 - 2026)

Analysis

Alvotech (ALVO) Operating Margin Growth (3y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 1,129.00
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -925.00
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -2,128.00
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 293.00
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 693.00
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -230,408.00
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 457.00
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -372.00
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 15,005.00
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -230,408.00
Dec 31, 2025 884,702.00
Jun 30, 2025 -42,154.00